Similar articles

• Oestrogens and postprandial lipid metabolism.

  Westerveld HT, Meyer E, de Bruin TW, Erkelens DW. Westerveld HT, et al. Biochem Soc Trans. 1997 Feb;25(1):45-9. doi: 10.1042/bst0250045. Biochem Soc Trans. 1997. PMID: 9056841 Review. No abstract available.
• [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].

  Brettes JP, Mathelin C. Brettes JP, et al. Gynecol Obstet Fertil. 2007 Nov;35(11):1092-4. doi: 10.1016/j.gyobfe.2007.09.003. Epub 2007 Nov 8. Gynecol Obstet Fertil. 2007. PMID: 17996474 French. No abstract available.
• The lost promise of hormone replacement therapy and heart disease.

  Maas AH. Maas AH. Semin Vasc Med. 2004 May;4(2):135-44. doi: 10.1055/s-2004-835371. Semin Vasc Med. 2004. PMID: 15478034 Review.
• The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.

  Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P. Bayrak A, et al. Arch Gynecol Obstet. 2006 Aug;274(5):289-96. doi: 10.1007/s00404-006-0187-2. Epub 2006 Jun 30. Arch Gynecol Obstet. 2006. PMID: 16810536
• Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.

  Ho JY, Chen MJ, Sheu WH, Yi YC, Tsai AC, Guu HF, Ho ES. Ho JY, et al. Hum Reprod. 2006 Oct;21(10):2715-20. doi: 10.1093/humrep/del245. Epub 2006 Jun 28. Hum Reprod. 2006. PMID: 16807281 Clinical Trial.